Home › Blood Cancers › Nevada › Las Vegas
Blood Cancers clinical trials in Las Vegas, NV
3 studies for Blood Cancers are looking for participants at sites in and around Las Vegas (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
RecruitingPhase 3
- Comprehensive Cancer Centers of Nevada ( Site 0043), Las Vegas
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- OptumCare Cancer Care at Charleston, Las Vegas
- University Medical Center of Southern Nevada, Las Vegas
- Hope Cancer Care of Nevada, Las Vegas
- and 16 more
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
RecruitingObservational study
- OptumCare Cancer Care at Charleston, Las Vegas
- University Medical Center of Southern Nevada, Las Vegas
- Hope Cancer Care of Nevada, Las Vegas
- and 16 more
Blood Cancers trials in other cities
- Houston, TX46 studies
- New York City, NY26 studies
- Boston, MA25 studies
- Washington, DC19 studies
- Baltimore, MD18 studies
- Seattle, WA18 studies
- Los Angeles, CA17 studies
- Durham, NC16 studies
- Chicago, IL15 studies
- Philadelphia, PA14 studies
- Atlanta, GA13 studies
- Nashville, TN13 studies
Other studies in Las Vegas
- Obesity27 studies
- Overweight23 studies
- Type 2 Diabetes18 studies
- Non-Small Cell Lung Cancer13 studies
- Major Depressive Disorder13 studies
- Breast Cancer10 studies
- Alzheimer's Disease8 studies
- Prostate Cancer8 studies
- Acute Myeloid Leukemia8 studies
- Cancer (all types)8 studies
- Steatotic Liver Disease7 studies
- Endometrial Cancer7 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.